Table 4. Clinicopathological variables for 5-year disease-free and overall survival in the multivariate analysis.
| Clinicopathological variables | β | SE | P value | Hazards ratio | 95% confidence interval |
|---|---|---|---|---|---|
| 5-year disease-free survival | |||||
| Quadrant (outer and upper-inner vs. lower-inner/central) | 0.626 | 0.272 | 0.021 | 1.870 | 1.099–3.185 |
| Pretreatment LMR (>5.2 vs. ≤5.2) | 1.007 | 0.267 | <0.001 | 2.737 | 1.623–4.618 |
| Histological grade (I–II vs. III) | 0.845 | 0.352 | 0.016 | 2.329 | 1.168–4.642 |
| Clinical stage (II vs. III) | 1.171 | 0.312 | <0.001 | 3.225 | 1.750–5.944 |
| 5-year overall survival | |||||
| Luminal subtype (luminal A vs. luminal B) | 1.688 | 0.616 | 0.006 | 5.407 | 1.616–18.088 |
| Pretreatment LMR (>5.2 vs. ≤5.2) | 0.932 | 0.423 | 0.028 | 2.539 | 1.108–5.819 |
| Histological grade (I–II vs. III) | 1.790 | 0.443 | <0.001 | 5.987 | 2.513–14.263 |
| Clinical stage (II vs. III) | 0.836 | 0.439 | 0.057 | 2.307 | 0.977–5.449 |
In the multivariate analysis, only variables with P<0.1 and other meaningful variables in the univariate analysis were included. LMR, lymphocyte-to-monocyte ratio; SE, standard error.